Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States.

Patients with RET fusions have different baseline characteristics that contribute to favorable OS in unadjusted analysis. However, after adjusting for baseline covariates, there were no significant differences in either OS or PFS by RET status among patients treated with standard therapy prior to the availability of selective RET inhibitors.